| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 33.686 | 86.139 | 70.296 | 79.283 |
| Total Income - EUR | - | - | - | - | - | - | 33.686 | 86.141 | 70.296 | 79.283 |
| Total Expenses - EUR | - | - | - | - | - | - | 6.005 | 29.987 | 58.392 | 75.975 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 27.681 | 56.154 | 11.904 | 3.308 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 26.983 | 54.668 | 11.290 | 2.816 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Raralg Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 20.225 | 22.626 | 30.804 |
| Current Assets | - | - | - | - | - | - | 29.496 | 38.426 | 35.602 | 26.609 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 23.668 | 12.729 | 4.348 |
| Cash | - | - | - | - | - | - | 29.496 | 14.758 | 22.873 | 22.261 |
| Shareholders Funds | - | - | - | - | - | - | 27.024 | 54.708 | 52.340 | 43.938 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 2.473 | 3.943 | 5.888 | 13.475 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8130 - 8130" | |||||||||
| CAEN Financial Year |
8130
|
|||||||||
Comments - Raralg Bio S.r.l.